companydata.dkNovo Nordisk North America Operations A/S: Financial statements 2022
CVR: 33761201
Novo Nordisk North America Operations A/S (CVR 33761201) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 31,296,000 and a net result of DKK 334,269,000 compared with DKK -467,036,000 the year before. That is a decrease of 83.4% compared with the year before. The profit margin was 1,068.1%. Equity amounted to DKK 639,162,000. The solvency ratio was 61.4%.
- Revenue
- 31,296,000 kr.
- Gross Profit
- 448,029,000 kr.
- Profit/Loss
- 334,269,000 kr.
- Equity
- 639,162,000 kr.
- Total Assets
- 1,040,898,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 31.3 mio. | 448 mio. | 334.3 mio. | 639.2 mio. | - |
| 2021 | 188.9 mio. | - | -467 mio. | 7.8 mia. | - |
| 2020 | - | - | 34.8 mio. | 9.2 mia. | - |
| 2019 | - | - | 189.9 mio. | 728.5 mio. | - |
| 2018 | - | - | 730 t. | 3.4 mio. | - |
Keep an eye on Novo Nordisk North America Operations A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Novo Nordisk North America Operations A/S has published its annual report for 2021. Revenue came to DKK 188,931,000, and the net result was DKK -467,036,000.
About Novo Nordisk North America Operations A/S
Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.